Intellia Therapeutics Names Laura Sepp-Lorenzino, Ph.D., Chief Scientific Officer

Go back to Intellia Therapeutics Names Laura Sepp-Lorenzino, Ph.D., Chief Scientific Officer
(NASDAQ: NTLA) Delayed: 13.05 -0.46 (3.4%)
Previous Close $13.51    52 Week High $30.40 
Open $13.38    52 Week Low $11.86 
Day High $13.50    P/E N/A 
Day Low $12.98    EPS $0.00 
Volume 1,263,609